Top Biomed Stock Signal: MLTX
Report Date: 01-28-2024
Symbol: MLTX - MoonLake Immunotherapeutics
Sector:
Industry:
Top Biomed Stock Signal: MLTX
MoonLake Immunotherapeutics (MLTX)
Dorfstrasse 29
Zug, 6300
Phone:
Website: https://www.moonlaketx.com
CEO:
NASDAQ, NASDAQ Global Market
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.